Manning Meredith

Chief Commercial Officer at SOLENO THERAPEUTICS INC

Sold, on record
$3.3M
Dollars the filings state
Form 4 sales
2
Latest Mar 27, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale SOLENO THERAPEUTICS INCUnusual
    Mar 27 2025

    Sold 45,249 shares at $67.28 ($3M)

    Manning Meredith, Chief Commercial Officer

    No 10b5-1 planSold 49.9% of holdings ($6.1M position)45,351 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale SOLENO THERAPEUTICS INCNo plan
    Mar 27 +365 days

    Sold 7,522 shares at $30.44 ($229k)

    Manning Meredith, Chief Commercial Officer

    No 10b5-1 planSold 10.4% of holdings ($2.2M position)64,507 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Manning Meredith
Source
Mar 27, 2026SOLENO THERAPEUTICS INCChief Commercial OfficerForm 4 sale7,522$229k10.4%No planSEC
Mar 27, 2025SOLENO THERAPEUTICS INCChief Commercial OfficerForm 4 sale45,249$3M49.9%UnusualSEC